Wesleyan Assurance Society’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.25M | Hold |
175,500
| – | – | 0.28% | 68 |
|
2025
Q1 | $4.45M | Sell |
175,500
-52,500
| -23% | -$1.33M | 0.33% | 68 |
|
2024
Q4 | $6.05M | Sell |
228,000
-2,500
| -1% | -$66.4K | 0.46% | 60 |
|
2024
Q3 | $6.67M | Hold |
230,500
| – | – | 0.53% | 53 |
|
2024
Q2 | $6.45M | Buy |
230,500
+40,000
| +21% | +$1.12M | 0.56% | 48 |
|
2024
Q1 | $5.28M | Buy |
190,500
+75,000
| +65% | +$2.08M | 0.47% | 55 |
|
2023
Q4 | $3.32M | Hold |
115,500
| – | – | 0.33% | 71 |
|
2023
Q3 | $3.83M | Hold |
115,500
| – | – | 0.43% | 62 |
|
2023
Q2 | $4.24M | Hold |
115,500
| – | – | 0.45% | 60 |
|
2023
Q1 | $4.71M | Hold |
115,500
| – | – | 0.55% | 54 |
|
2022
Q4 | $5.92M | Sell |
115,500
-5,000
| -4% | -$256K | 0.73% | 47 |
|
2022
Q3 | $5.28M | Hold |
120,500
| – | – | 0.81% | 44 |
|
2022
Q2 | $6.33M | Hold |
120,500
| – | – | 0.91% | 42 |
|
2022
Q1 | $6.24M | Buy |
120,500
+47,500
| +65% | +$2.46M | 0.76% | 43 |
|
2021
Q4 | $4.31M | Hold |
73,000
| – | – | 0.51% | 59 |
|
2021
Q3 | $3.14M | Hold |
73,000
| – | – | 0.4% | 67 |
|
2021
Q2 | $2.86M | Hold |
73,000
| – | – | 0.36% | 72 |
|
2021
Q1 | $2.65M | Hold |
73,000
| – | – | 0.35% | 73 |
|
2020
Q4 | $2.69M | Sell |
73,000
-3,942
| -5% | -$145K | 0.39% | 71 |
|
2020
Q3 | $2.68M | Hold |
76,942
| – | – | 0.44% | 64 |
|
2020
Q2 | $2.39M | Buy |
76,942
+21,080
| +38% | +$654K | 0.42% | 66 |
|
2020
Q1 | $1.73M | Buy |
55,862
+18,972
| +51% | +$588K | 0.37% | 66 |
|
2019
Q4 | $1.37M | Hold |
36,890
| – | – | 0.26% | 70 |
|
2019
Q3 | $1.26M | Hold |
36,890
| – | – | 0.25% | 72 |
|
2019
Q2 | $1.52M | Hold |
36,890
| – | – | 0.3% | 68 |
|
2019
Q1 | $1.49M | Buy |
+36,890
| New | +$1.49M | 0.31% | 68 |
|